UK-based biotech Synthace has secured £1.3m ($2.09m) in seed backing in a round led by venture firm Sofinnova Partner’s Green Seed Fund and joined by angel investors.

The University College London (UCL) spin-out, founded in 2011, is developing a platform of technologies aimed at the rapid engineering and optimisation of biological production systems. Through utilising micro-organisms, Synthace can produce sustainable and renewable chemical and biological products.

In addition to the equity funding, Synthace benefitted from a £500k award from the…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?